(1,2-dioxoethylene)bis(iminoethylene) bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]

Acute Toxicity: inhalation

Administrative data

Endpoint:

acute toxicity: inhalation

Type of information:

experimental study

Adequacy of study:

key study

Study period:

29 November 2017 to 17 January 2018

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2018

Report date:

2018

Materials and methods

Test guideline

Test guideline 1

Qualifier:

according to guideline

Guideline:

OECD Guideline 403 (Acute Inhalation Toxicity)

Version / remarks:

OECD Guideline for the Testing of Chemicals No. 403 “Acute Inhalation Toxicity”, adopted: 07 September 2009.

Deviations:

yes

Remarks:

See "Any other information" for details

Test guideline 2

Qualifier:

according to guideline

Guideline:

EU Method B.2 (Acute Toxicity (Inhalation))

Version / remarks:

EC 440/2008, Annex Part B, (2008) Method B2

Deviations:

yes

Remarks:

See "Any other information" for details

Test guideline 3

Qualifier:

according to guideline

Guideline:

EPA OPPTS 870.1300 (Acute inhalation toxicity)

Version / remarks:

US Environmental Protection Agency (EPA) Health Effects Division Test Guidelines, OPPTS 870.1300, Acute Inhalation Toxicity, (August 1998)

Deviations:

yes

Remarks:

See "Any other information" for details

GLP compliance:

yes (incl. QA statement)

Test type:

traditional method

Limit test:

yes

Test material

Test material information

Constituent 1

Reference substance name:

(1,2-dioxoethylene)bis(iminoethylene) bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]

EC Number:

274-572-7

EC Name:

(1,2-dioxoethylene)bis(iminoethylene) bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]

Cas Number:

70331-94-1

Molecular formula:

C40H60N2O8

IUPAC Name:

(1,2-dioxoethylene)bis(iminoethylene) bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]

Test material form:

solid: particulate/powder

Details on test material:

Test Item Name: NAUGARD® XL-1
Laboratory Master Schedule No. at FumoPrep Ltd.: 4174
Manufacturer: Addivant USA LLC
Chemical Name: (1,2-dioxoethylene)bis(iminoethylene) bis[3-(3,5-di-tertbutyl-4-hydroxyphenyl)propionate]
Batch/Lot Number: 11608030
CAS Number: 70331-94-1
Appearance: White powder
Manufacture Date: 30 August 2016
Expiry Date: 29 August 2020
Purity: 99.4%
Storage: Condition Controlled room temperature (15-25 °C) protected from light
Safety Precautions: Routine safety precautions (gloves, goggles, face mask, lab coat) for unknown materials were applied to assure personnel health and safety.

Specific details on test material used for the study:

No further details specified in the study report.

Test animals

Species:

rat

Strain:

Wistar

Sex:

male/female

Details on test animals or test system and environmental conditions:

Male and female Wistar Crl:WI rats (from SPF colony) were obtained from Charles River Laboratories, Research Model and Services, Germany GmbH (Sandhofer Weg 7, D-97633, Sulzfeld, Germany).
After arrival, the animals’ health was certified by the resident veterinarian.
Hygienic level at arrival: SPF
Hygienic level during the study: Standard housing conditions
Justification of strain: Recognized by international guidelines as a recommended test system
Animal room: 245/4
Number of animals: 12 (6 animals/sex)
Sex: Male and female, the females were nulliparous and non-pregnant
Age and body weight range of animals on the exposure day (Day 0) were:
Sighting exposure (Group 0.1): approximately 8 weeks old, 346 g (male) and 232 g (female)
Main study (Group 1): approximately 10 weeks old, 424-484 g (males) and 240-262 g (females).

Justification
Rats are the preferred species as they have been used historically for safety evaluation studies and they are specified by the appropriate regulatory authorities. Citoxlab Hungary Ltd. also has considerable experience with this species and historical control data in which to set the findings in context.

Husbandry
Housing: Group caging (5 animals, by sex, per cage), individual caging during the sighting study
Cage type: Polycarbonate solid floor cages (type II or III) with stainless steel mesh lids.
Light: 12 hours of continuous artificial light in each twenty-four hour period (from 6.00 a.m. to 6.00 p.m.)
Temperature: 16.4 – 26.2 °C (245/4)
Relative humidity: 31 – 59 % (245/4)
Ventilation: At least 15 air exchanges per hour.
The temperature and relative humidity were recorded twice daily during the study.

Diet and Water
The animals were provided with ssniff SM R/M “Autoclavable Complete Feed for Rats and Mice – Breeding and Maintenance” (ssniff Spezialdiäten GmbH, D-59494 Soest Germany) ad libitum, and tap water from the municipal supply, as for human consumption from 500 ml bottles ad libitum.
Water quality control analysis is performed once every 3 months and microbiological assessment is performed monthly, by Veszprém County Institute of State Public Health and Medical Officer Service (ÁNTSZ, H-8201 Veszprém, József A.u.36, Hungary). The quality control results are retained in the archive of Citoxlab Hungary Ltd.
The food and drinking water were considered not to contain any contaminants that could reasonably be expected to affect the purpose or integrity of the study.

Bedding
Lignocel® Hygienic Animal Bedding produced by J. Rettenmaier & Söhne GmbH+Co. KG (Holzmühle 1, D-73494 Rosenberg, Germany), was used. The quality of the bedding material was guaranteed by the supplier. Nest building material (ARBOCEL crinklets natural (produced by J. Rettenmaier & Söhne GmbH & Co.KG, Germany)) was also added to the cages. Copies of the certificates are retained in the archives of Citoxlab Hungary Ltd.
The bedding and the nest building material were considered not to contain any contaminants that could reasonably be expected to affect the purpose or integrity of the study.

Acclimation and randomization
Animals were acclimated to laboratory conditions for 7 (sighting group) or 26 days (main study) prior to involvement in the study. Animals were also acclimatised to the test apparatus (restraint procedures) for a short period prior to testing in order to lessen the stress during exposure.
Animals were randomly allocated to exposure groups before animal exposure based on the actual body weights.

Identification
Animals were individually identified with numbers written on the tail with an indelible marker. The numbers were given on the basis of Citoxlab Hungary Ltd.'s master file.
Cages were identified by cards holding information on the study code, the sex of animals, the dose group, the cage number and the individual animal number.

Administration / exposure

Route of administration:

inhalation: aerosol

Type of inhalation exposure:

nose only

Vehicle:

air

Mass median aerodynamic diameter (MMAD):

> 1 - < 4 µm

Geometric standard deviation (GSD):

> 1.3 - < 3

Remark on MMAD/GSD:

Prior to animal exposures, test material atmospheres were generated within the exposure chamber. During these technical trials, air-flow settings, test material input rates and test item formulation of the material were varied to achieve the required aerosol concentration of particles with a mass median aerodynamic diameter (MMAD) between 1 to 4 µm and a geometric standard deviation (GSD) in the range of 1.5 to 3.0. Measurements of aerodynamic particle size were performed from the animal’s breathing zone using a cascade impactor

Details on inhalation exposure:

The test item was aerosolised using Wright’s Dust Feed Systems (TSE Systems GmbH, Bad Homburg, Germany; Serial Number: 040804-59) located at the top of the exposure chamber. Compressed air was supplied by means of an oil-free compressor passed through a suitable filter system prior to introduction to the aerosol generator.
Compressed air was supplied by means of an oil-free compressor and passed through a suitable filter system prior to introduction to the nebuliser.

Analytical verification of test atmosphere concentrations:

yes

Duration of exposure:

4 h

Concentrations:

The mean achieved atmosphere concentrations in the study were 5.07 mg/L in Group 0.1 (sighting study), and 5.01 mg/L in Group 1 (main study).

No. of animals per sex per dose:

Sighting study: 2 animals (1 male/1 female)
Mian study: 10 animals (5 males/5 females)

Control animals:

no

Details on study design:

Study design
The animals were exposed to an atmosphere of the test item for a single, continuous four-hour period, generated according to the system and flow rates determined during the technical trials. The study was conducted according to the following design.

Animal exposure system
The animals were exposed, nose-only, to an atmosphere of the test item using a TSE Rodent Exposure System (TSE Systems GmbH, Bad Homburg, Germany). This system comprises of two concentric anodised aluminium chambers and a computer control system incorporating pressure detectors and mass flow controllers.
The exposure unit was placed in closed hood in order to avoid cross-contamination and contamination of the laboratory environment.
Fresh aerosol from the generation system was constantly supplied to the inner plenum (distribution chamber) of the exposure system from where, under positive pressure, it was distributed to the individual exposure ports. The animals were held in polycarbonate restraint tubes located around the chamber which allowed only the animal’s nostrils to enter the exposure port. After passing through the animal’s breathing zone, used aerosol entered the outer cylinder from where it was exhausted through a suitable filter system. Atmosphere generation was therefore dynamic.
Airflows and relative pressures within the system were constantly monitored and controlled by the computer system thus ensuring a uniform distribution and constant flow of fresh aerosol to each exposure port (breathing zone). The flow of air through each port was at least 0.5 L/min. This flow rate was considered adequate to minimize re-breathing of the test atmosphere as it is approximately twice the respiratory minute volume of a rat.
Homogeneity of the test atmosphere within the test chamber and amongst the exposure ports was not specifically determined during this study. However, considerably larger chambers of this design have been fully validated and have shown to produce evenly distributed atmospheres in the animals’ breathing zones.

Sighting Exposure
Sighting exposures were performed in order to estimate the test item’s inhalation toxicity, identify sex differences in susceptibility and assist in selecting exposure concentration levels for the main study.

Exposure procedure
Each rat was individually held in a tapered, polycarbonate restraining tube fitted onto a single tier of the exposure chamber. Only the nose of each animal was exposed to the test atmosphere.
Following an equilibration period of at least the theoretical chamber equilibration time (T99), each group of rats was exposed to an atmosphere of the test material for a period of 4 hours.
No control animals were used in the study; the effects of the acetone vehicle are well known.

Exposure Monitoring
Test atmosphere concentrations
The test atmosphere was sampled at regular intervals during the exposure period. Samples were taken from an unoccupied exposure port (representing the animal’s breathing zone) by pulling a suitable volume of test atmosphere through weighed GF10 glass fibre filters (Whatman®, Whatman GmbH, Germany, Ref./Lot no.: G9768136).
The difference in the pre and post sampling weights, divided by the volume of atmosphere sampled, was equal to the actual achieved test atmosphere concentration.
Filter samples (17) were collected at the breathing zone (approximately every 10-20 minutes) during each 4-hour exposure period and measured.
The nominal concentration was calculated by dividing the mass of test material disseminated into the chamber by the total volume of air that flow through the chamber during the same period.

Particle size analysis
The particle size of the test atmosphere was determined three times during the exposure period using a 7-stage impactor of Mercer style (TSE Systems GmbH, Bad Homburg, Germany). Such devices employ an inertial separation technique to isolate particles in the discrete aerodynamic size ranges. Samples were taken from an unoccupied exposure port (representing the animal’s breathing zone).
The collection substrates and the backup filter were weighed before and after sampling and the weight of test item, collected at each stage, calculated by this difference.
The total amount collected for each stage was used to determine the cumulative amount below each cut-off point size. In this way, the proportion (%) of aerosol less than < 0.550, 0.550, 0.960, 1.550, 2.105, 3.555, 6.655 and 10.550 m was calculated.
From these data, using the software supplied with the impactor (TSE Systems GmbH, Bad Homburg, Germany), the Mass Median Aerodynamic Diameter (MMAD), and Geometric Standard Deviation (GSD) were calculated. In addition, the proportion (%) of aerosol less than 4 m (considered to be the inhalable portion) was determined.

Chamber environmental conditions
The following variables were monitored continuously and recorded at regular intervals during each exposure period by a validated monitoring system integrated into the exposure system:
-Chamber airflow rates
-Test atmosphere temperature
--Test atmosphere relative humidity
-Test atmosphere carbon dioxide concentration
-Test atmosphere oxygen concentration

Observations
Morbidity/mortality
Animals were checked hourly during exposure, 1 hour after exposure and twice daily (early and late in the working day) during the 14-day observation period for morbidity and/or mortality.

Clinical signs
All animals were observed for clinical signs at hourly intervals during exposure whilst the animals were still restrained. Following exposure, clinical observations were performed twice on the day of exposure (following removal from the restrainer and approximately one hour after completion of the exposure) and subsequently once daily for 14 days.
Observations included changes in the skin and fur, eyes and mucous membranes and also respiratory, circulatory, autonomic and central nervous system, somato-motor activity and behaviour pattern. Particular attention was directed to observation of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma.

Body weight
Individual body weights were recorded prior to treatment on the day of exposure (on Day 0) and on Days 1, 3, 7 and 14.

Necropsy
At the end of the 14-day observation period, the surviving animals were sacrificed by exsanguination under anaesthesia (intra-peritoneal injection of pentobarbital solution – Euthanimal 40%; Lot No.: 1609291-03; Expiry: October 2019; Produced by Alfasan International B. V., Woerden, Netherlands) and gross macroscopic examination was performed.
All rats were subject to a gross necropsy which included a detailed examination of the abdominal and thoracic cavities. Special attention was given to the respiratory tract for macroscopic signs of irritancy or local toxicity.

Statistics:

Only a limit test was performed, the four-hour inhalation LC50 was not calculated.

Results and discussion

Preliminary study:

Sighting Study: Group 0.1 (5.07 mg/L with 1♂+1♀): Laboured respiration (slight to moderate) was observed on the day of the treatment. The animals were symptom free from Day 1.

Effect levels

Key result

Sex:

male/female

Dose descriptor:

LC50

Effect level:

> 5.01 mg/L air (nominal)

Based on:

test mat.

Exp. duration:

4 h

Mortality:

There was no mortality in the study.

Clinical signs:

other: Wet fur, red-brown staining or fur staining were commonly recorded on the day of the exposure, which were considered to be related to the restraint and exposure procedures but not to be toxicologically significant. The following observations were consider

Body weight:

In Group 0.1, no or minimal body weight loss (3.8 %) was recorded on the day of treatment. In the observation period, normal body weight gain was recorded in both animals.
In Group 1, minimal to slight body weight loss (0.4 – 10.1 %) was recorded on the day of treatment. In the observation period, normal body weight gain was recorded in all animals.

Gross pathology:

A single four hours nose-only exposure of NAUGARD®XL-1 to Wistar Crl: WI rats dosed at 5.07 mg/L in Sighting exposure or 5.01 mg/L in Main study for 14 days was not associated with any test item-related gross changes.

Any other information on results incl. tables

Mean achieved actual and minimal aerosol concentration

Part of study	Target Concentration (mg/L)	Mean Achieved Concentration (mg/L)	Standard Deviation of Achieved Concentration (mg/L)	Nominal Concentration (mg/L)
Sighting exposure: Group 0.1	5	5.07	0.19	16.65
Main study: Group 1	5	5.01	0.21	17.48

 

Mean achieved particle size distribution data (MMAD and GSD)

Part of study	Target Concentration (mg/L)	Mean Mass Median Aerodynamic Diameter (MMAD) (μm)	Geometric Standard Deviation (GSD)	Inhalable Fraction (% < 4μm)
Sighting exposure: Group 0.1	5	3.73	2.35	53.2
Main study: Group 1	5	3.76	2.48	52.6

 

Test Atmosphere Concentrations

Group 0.1 (Sighting study)

Exposure Duration (minutes)	Sample Volume (L)	Atmospheric Concentration of NAUGARD® XL-1 (mg/L)
0	2.0	4.90
13	2.0	4.92
24	2.0	5.01
35	2.0	5.03
50	2.0	5.15
62	2.0	5.21
77	2.0	4.88
94	2.0	5.06
108	2.0	5.09
121	2.0	5.11
138	2.0	5.02
153	2.0	5.17
168	2.0	4.56
183	2.0	5.37
198	2.0	5.31
212	2.0	5.23
227	2.0	5.11

Mean Achieved Atmosphere Concentration = 5.07 mg/L

Standard Deviation = 0.19

Nominal Concentration:

Amount of Test Item Used (g): 125.90

Total Volume of Air Used (L): 7560

Nominal Concentration = 16.65 mg/L

 

Group 1 (Main study)

Exposure Duration (minutes)	Sample Volume (L)	Atmospheric Concentration of NAUGARD® XL-1 (mg/L)
0	2.0	4.91
12	2.0	4.82
24	2.0	4.95
36	2.0	5.12
45	2.0	5.13
63	2.0	4.93
78	2.0	5.24
93	2.0	5.30
108	2.0	5.26
123	2.0	5.28
138	2.0	4.70
153	2.0	4.70
168	2.0	5.02
183	2.0	4.90
199	2.0	5.21
213	2.0	4.77
228	2.0	4.87

Mean Achieved Atmosphere Concentration = 5.01 mg/L

Standard Deviation = 0.21

Nominal Concentration:

Amount of Test Item Used (g): 137.41

Total Volume of Air Used (L): 7860

Nominal Concentration = 17.48 mg/L

 

Mortality Data

Day Number	Number of Deaths
	Group 0.1 (Sighting study)(5.07 mg/L)		Group 1  (Main study)  (5.01 mg/L)
	Male	Female	Male	Female
0 (During exposure)	0	0	0	0
0 (After exposure)	0	0	0	0
1	0	0	0	0
2	0	0	0	0
3	0	0	0	0
4	0	0	0	0
5	0	0	0	0
6	0	0	0	0
7	0	0	0	0
8 – 14	0	0	0	0
Total Deaths	0/1	0/1	0/5	0/5
Grand Total Deaths	0/2		0/10

 

Individual Clinical Observations

SIGHTING EXPOSURE

DOSE GROUP: 0.1

CONCENTRATION: 5.07 mg/L

Animal number

Observations

Days of study

Frequency

0 (exposure)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

During

After

1h

2h

3h

4h

5h

2110M

Normal Laboured Respiration – Slight Laboured Respiration – Moderate Wet fur – Whole body Fur staining by test item – Nose

+ - - - -

- + - - -

- - + - -

- - + + +

- + - + -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

15 /19 2 /19 2 /19 2 /19 1 /19

2128F

Normal Laboured Respiration – Slight Laboured Respiration – Moderate Wet fur – Whole body Fur staining by test item - Nose

+ - - - -

- + - - -

- - + - -

- - + + +

- + - + -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

+ - - - -

15 /19 2 /19 2 /19 2 /19 1 /19

COMMENT:

+ = Present          - = Absent

 

MAIN STUDY

DOSE GROUP: 1

CONCENTRATION: 5.01 mg/L                                                                                                                                      SEX: MALE

Animal number

Observations

Days of study

Frequency

0 (exposure)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

During

After

1h

2h

3h

4h

5h

2120

Normal Laboured Respiration – Slight Fur staining by test item – Nose Red-brown staining – Nose

+ - - -

+ - - -

- + - -

- + + +

- + + +

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

16 /19 3 /19 2 /19 2 /19

2121

Normal Laboured Respiration – Slight Fur staining by test item – Nose Red-brown staining – Nose

+ - - -

+ - - -

- + - -

- + + +

- + + +

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

16 /19 3 /19 2 /19 2 /19

2122

Normal Laboured Respiration – Slight Fur staining by test item – Nose Red-brown staining – Nose

+ - - -

+ - - -

- + - -

- + + +

- + + +

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

16 /19 3 /19 2 /19 2 /19

2123

Normal Laboured Respiration – Slight Fur staining by test item – Nose Red-brown staining – Nose

+ - - -

+ - - -

- + - -

- + + +

- + + +

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

16 /19 3 /19 2 /19 2 /19

2124

Normal Laboured Respiration – Slight Fur staining by test item – Nose Red-brown staining – Nose

+ - - -

+ - - -

- + - -

- + + +

- + + +

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

16 /19 3 /19 2 /19 2 /19

COMMENT:

+ = Present          - = Absent

 

MAIN STUDY

DOSE GROUP: 1

CONCENTRATION: 5.01 mg/L                                                                                                                                      SEX: FEMALE

Animal number

Observations

Days of study

Frequency

0 (exposure)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

During

After

1h

2h

3h

4h

5h

2135

Normal Laboured Respiration – Slight Fur staining by test item – Nose Red-brown staining – Nose

+ - - -

+ - - -

- + - -

- + + +

- + + +

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

16 /19 3 /19 2 /19 2 /19

2136

Normal Laboured Respiration – Slight Fur staining by test item – Nose Red-brown staining – Nose

+ - - -

+ - - -

- + - -

- + + +

- + + +

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

16 /19 3 /19 2 /19 2 /19

2137

Normal Laboured Respiration – Slight Fur staining by test item – Nose Red-brown staining – Nose

+ - - -

+ - - -

- + - -

- + + +

- + + +

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

16 /19 3 /19 2 /19 2 /19

2138

Normal Laboured Respiration – Slight Fur staining by test item – Nose Red-brown staining – Nose

+ - - -

+ - - -

- + - -

- + + +

- + + +

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

16 /19 3 /19 2 /19 2 /19

2139

Normal Laboured Respiration – Slight Fur staining by test item – Nose Red-brown staining – Nose

+ - - -

+ - - -

- + - -

- + + +

- + + +

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

+ - - -

16 /19 3 /19 2 /19 2 /19

COMMENT:

+ = Present          - = Absent

 

Individual Body Weight Data

SIGHTING EXPOSURE

DOSE GROUP: 0.1

CONCENTRATION: 5.07 mg/L                                                                           SEX: MALE/FEMALE

Animal Number	Body weight (g) on days					Day/B.W. (g) Death	Body weight gain (g) between days
	0	1	3	7	14		0-1	1-3	3-7	7-14	0-14
2110M	346	333	353	389	428	-	-13	30	36	39	82
2128F	232	232	241	250	265	-	0	9	9	15	33

 

MAIN STUDY

DOSE GROUP: 1

CONCENTRATION: 5.01 mg/L                                                                           SEX: MALE

Animal Number	Body weight (g) on days					Day/B.W. (g) Death	Body weight gain (g) between days
	0	1	3	7	14		0-1	1-3	3-7	7-14	0-14
2120	443	418	436	454	475	-	-25	18	18	21	32
2121	454	443	452	473	507	-	-11	9	21	34	53
2122	484	454	471	488	525	-	-30	17	17	37	41
2123	444	440	449	471	500	-	-4	9	22	29	56
2124	424	381	381	395	441	-	-43	0	14	46	17

DOSE GROUP: 1

CONCENTRATION: 5.01 mg/L                                                                           SEX: FEMALE

Animal Number	Body weight (g) on days					Day/B.W. (g) Death	Body weight gain (g) between days
	0	1	3	7	14		0-1	1-3	3-7	7-14	0-14
2135	240	231	242	247	256	-	-9	11	5	9	16
2136	262	258	264	291	292	-	-4	6	27	1	30
2137	251	232	242	252	259	-	-19	10	10	7	8
2138	259	258	263	267	280	-	-1	5	4	13	21
2139	255	245	249	251	255	-	-10	4	2	4	0

- = No data

 

Individual Necropsy Findings

SIGHTING EXPOSURE

DOSE GROUP: 0.1

CONCENTRATION: 5.07 mg/L               SEX: MALE/FEMALE

NECROPSY FINDINGS	Animal numbers
	2110M	2128F
NO INTERNAL OBSERVATION RECORDED	+	+
NO EXTERNAL OBSERVATION RECORDED	+	+
STUDY DAYS	14	14
DATE OF NECROPSY	29 December 2017

 

MAIN STUDY

DOSE GROUP: 1

CONCENTRATION 5.01 mg/L                                                                                                   SEX: MALE

NECROPSY FINDINGS	Animal Numbers
	2120	2121	2122	2123	2124
NO INTERNAL OBSERVATION RECORDED	+	+	+	+	+
NO EXTERNAL OBSERVATION RECORDED	+	+	+	+	+
STUDY DAYS	14	14	14	14	14
DATE OF NECROPSY	17 January 2018

DOSE GROUP: 1

CONCENTRATION 5.01 mg/L                                                                                                   SEX: FEMALE

NECROPSY FINDINGS	Animal Numbers
	2135	2136	2137	2138	2138
NO INTERNAL OBSERVATION RECORDED	+	+	+	+	+
NO EXTERNAL OBSERVATION RECORDED	+	+	+	+	+
STUDY DAYS	14	14	14	14	14
DATE OF NECROPSY	17 January 2018

COMMENT: PRESENT = +

Applicant's summary and conclusion

Interpretation of results:

GHS criteria not met

Conclusions:

Under the experimental conditions of this study, no death occurred in a group of 10 Wistar Crl:WI rats (main study) that were exposed to a test atmosphere concentration of 5.01 mg/L for 4 hours. The acute inhalation median lethal concentration (LC50) of NAUGARD® XL-1 in Wistar Crl:WI rats was therefore considered to be above 5.01 mg/L.

Executive summary:

Study Design

Wistar Crl:WI rats were exposed to NAUGARD® XL-1 at the concentration of 5.01 mg/L.

 

The study was performed in multiple steps. A sighting exposure was performed first, where a test atmosphere of NAUGARD® XL-1 at 5.07 mg/L concentration was tested on single animals of both sexes (Group 0.1). As both animals survived the treatment, the main study group (Group 1) of 5 male and 5 female Crl:WI Wistar strain rats were exposed to an aerosol atmosphere of NAUGARD® XL-1 at the concentration of 5.01 mg/L.

 

In all study phases, the animals were exposed to the test atmosphere for 4 hours using a nose-only exposure system. Aerosol concentration was measured gravimetrically 17 times during each 4-hour exposure in both parts of the study and the particle size distribution of the test aerosol was determined 3 times. The day of exposure was designated as Day 0 followed by a 14-day observation period.

 

Clinical observations were performed on all animals during exposure at hourly intervals, following removal from restraint, approximately 1 hour after exposure, and daily for 14 days thereafter, as applicable. Body weight was measured on Days 0 (before the exposure), 1, 3, 7 and 14. Gross necropsy was performed on all animals sacrificed on Day 14.

 

No control group was exposed in this study.

 

Results

The quality of the test atmosphere fully complied with criteria documented in the respective guidelines: OECD 403, EPA OPPTS 870.1300 and Council Regulation (EC) No 440/2008.

 

The mean achieved atmosphere concentrations in the study were 5.07 mg/L in Group 0.1 (sighting study), and 5.01 mg/L in Group 1 (main study). The mass median aerodynamic diameters (MMAD) were 3.73 µm and 3.76 µm with geometric standard deviations (GSD) of 2.35 and 2.48 in the Sighting Group and the Main Group respectively.

 

Mortality

There was no mortality in the study.

 

Clinical observations

Wet fur, red-brown staining or fur staining were commonly recorded on the day of the exposure, which were considered to be related to the restraint and exposure procedures but not to be toxicologically significant.

 

The following observations were considered to be related to exposure to the atmospheres:

Group 0.1 (5.07 mg/L with 1♂+1♀): Laboured respiration (slight to moderate) was observed on the day of the treatment. The animals were symptom free from Day 1.

Group 1 (5.01 mg/L with 5♂+5♀): Laboured respiration (slight) was recorded on the day of exposure. The animals were symptom free from Day 1.

 

Body weight

In Group 0.1, no or minimal body weight loss (3.8 %) was recorded on the day of treatment. In the observation period, normal body weight gain was recorded in both animals.

In Group 1, minimal to slight body weight loss (0.4 – 10.1 %) was recorded on the day of treatment. In the observation period, normal body weight gain was recorded in all animals.

 

Necropsy

A single four hours nose-only exposure of NAUGARD®XL-1 to Wistar Crl: WI rats dosed at 5.07 mg/L in Sighting exposure or 5.01 mg/L in Main study for 14 days was not associated with any test item-related gross changes.

 

Conclusion

Under the experimental conditions of this study, no death occurred in a group of 10 Wistar Crl:WI rats (main study) that were exposed to a test atmosphere concentration of 5.01 mg/L for 4 hours. The acute inhalation median lethal concentration (LC50) of NAUGARD® XL-1 in Wistar Crl:WI rats was therefore considered to be above 5.01 mg/L.